INDIANAPOLIS (dpa-AFX) - Drugmaker Eli Lilly and Co. (LLY) Tuesday said John Lechleiter, chairman, president and chief executive officer, underwent scheduled surgery for a dilated aorta on May 13.
Kristine Courtney, senior director of Lilly's corporate health services, said, 'Dr. Lechleiter's surgeons have advised us that surgery went as expected and the repair to the aorta is functioning as intended. Dr. Lechleiter is recovering and will be closely monitored by the medical staff over the next several days.'
As announced earlier, in accordance with the company's bylaws, Derica Rice, executive vice president, global services and chief financial officer, has assumed the additional role of acting chief executive officer during Lechleiter's recuperation period. Ellen Marram, currently the board's lead independent director, is serving as acting chairperson of the board of directors.
Copyright(c) 2013 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2013 AFX News
